Use of a liposome antigen delivery system to alter immune responses in vivo

Journal of Pharmaceutical Sciences

Volumn 87, Issue 11, 1998, Pages 1428-1432

  Lutsiak, Christine M E ^a   Sosnowski, Deborah L ^a   Wishart, David S ^a   Kwon, Glen S ^b   Samuel, John ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b St Luke's Sinai Samaritan Med C

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 4; LIPOSOME; MPLA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 0031733729     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980075p     Document Type: Conference Paper

References (31)

1. Patel, S. S.; Duby, A. D.; Thiele, D. L.; Lipsky, P. E. Phenotypic and functional characterization of human T cell clones. J. Immunol. 1988, 141, 3726-36.
2. Mosmann, T. R.; Cherwinski, H.; Bond, M. W.; Giedlin, M. A.; Coffman, R. L. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 736, 2348-2357.
3. Mosmann, T. R.; Coffman, R. L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 1989, 46, 111-47.
4. Mosmann, T. R.; Coffman, R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Anna. Rev. Immunol. 1989, 7, 145-73.
5. Fiorentino, D. F.; Bond, M. W.; Mosmann, T. R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Thl clones. J. Exp. Med. 1989, 170, 2081-95.
6. Florentine, D. F.; Zlotnik, A.; Vieira, P.; Mosmann, T. R.; Howard, M.; Moore, K. W. A. O. G. IL-10 acts on the antigenpresenting cell to inhibit cytokine production by Thl cells. J. Immunol. 1991, 146, 3444-51.
7. Bretscher, P. A.; Wei, G.; Menon, J. N.; Bielefeldt-Ohmann, H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishrnania major. Science 1992, 257, 539-42.
8. Parish, C. R. The relationship between humoral and cellmediated immunity. Transplant. Rev. 1972, 13, 35-66.
9. Heinzel, F. P.; Sadick, M. D.; Mutha, S. S.; Locksley, R. M. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Nat. Acad. Sei. U.SA. 1991, 88, 7011-5.
10. Locksley, R. M.; Scott, P. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol. Today 1991, 12, A58-61.
11. Salk, J.; Bretscher, P. A.; Salk, P. L.; Clerici, M.; Shearer, G. M. A strategy for prophylactic vaccination against HIV. Science 1993, 260, 1270-2.
12. Beasley, R. P.; Hwang, L. Y.; Lin, C. C.; Chien, C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981, 2, 112933.
13. Penna, A.; Chisari, F. V.; Bertoletti, A.; Missale, G.; Fowler, P.; Giuberti, T.; Fiaccadori, F.; Ferrari, C. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 1991, 174, 1565-1570.
14. Milich, D. R.; Peterson, D. L.; Schodel, F.; Jones, J. E.; Hughes, J. L. Preferential recognition of hepatitis B nucleocapsid antigens by Thl or Th2 cells is epitope and major histocompatibility complex dependent. J. Virol. 1995, 69, 2776-85.
15. Wang, S. S. p-alkoxybenzyl alcohol resin and p-alkoxybenzyloxycarbonylhydrazide resin for solid phase synthesis of protected peptide fragments. J. Am. Chem. 1973, 95, 13281333.
16. Rink, H. Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resin. Tetrahedron Lett. 1987, 28, 3787-3790.
17. Fields, G. B. Noble, R. L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990, 35, 161-214.
18. Pick, U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch. Biochem. Biophys. 1981, 212, 186-94.
19. Tham, K. M.; Studdert, M. J. Nylon wool column fractionation and characterization of feline lymphocyte subpopulations. Vet. Immunol. Immunopathol. 1985, 8, 3-13.
20. Graham, M. B.; Braciale, V. L.; Braciale, T. J. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 1994, 180, 1273-82.
21. Maeda, H.; Shiraishi, A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 1996, 156, 73-8.
22. Moran, T. M.; Isobe, H.; Fernandez-Sesma, A.; Schulman, J. L. Interleukin-4 causes delayed virus clearance in influenza virus-infected mice. J. Virol. 1996, 70, 5230-5.
23. Yoshida, T.; Hachimura, S.; Kaminogawa, S. The oral administration of low-dose antigen induces activation followed by tolerization, while high-dose antigen induces tolerance without activation. Clin. Immunol. Immunopathol. 1997, 82, 207-15.
24. Naquet, P.; Ellis, J.; Kenshole, A.; Semple, J. W.; Delovitch, T. L. Sulfated beef insulin treatment elicits CD8+ T cells that may abrogate immunologie insulin resistance in type I diabetes. J. Clin. Invest. 1989, 84, 1479-87.
25. Samuel, J.; Budzynski, W. A.; Reddish, M. A.; Ding, L.; Zimmermann, G. L.; Krantz, M. J.; Koganty, R. R.; Longenecker, B. M. Immunogenicity and antitumor activity of a liposomal MUC1 peptide-based vaccine. Int. J. Cancer 1998, 75, 295-302.
26. Newman, K. D.; Samuel, J. Kwon, G. Ovalbumin peptide encapsulated in poly (d, l lactic-co-glycolic acid) microspneres is capable of inducing a T helper type 1 immune response. J. Cont. Release, in press.
27. Guan, H. H.; Budzynski, W.; Koganty, R.; Krantz, M. J.; Reddish, M. A.; Rogers, J. A.; Longenecker, B. M.; Samuel, J. Liposomal formulation of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. Bioconjugate Chem. in press.
28. Murray, H. W.; Hariprashad, J. Interleukin 12 is effective treatment for an established systemic intracellular infec-tion: experimental visceral leishmaniasis. J. Exp. Med. 1995, 181, 387-91.
29. Wang, Z. E.; Zheng, S.; Corry, D. B.; Dalton, D. K.; Seder, R. A.; Reiner, S. L.; Locksley, R. M. Interferon gammaindependent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proc. Nat. Acad. Sei. U.SA. 1994, 91, 12932-6.
30. Saha, B.; Das, G.; Vohra, H.; Ganguly, N. K.; Mishra, G. C. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity. Eur. J. Immunol. 1995, 25, 2492-8.
31. Saha, B.; Das, G.; Vohra, H.; Ganguly, N. K.; Mishra, G. C. Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response. Kur. J. Immunol. 1994, 24, 2618-24.